Search details
1.
Survival of eight LLIN brands 6, 12, 24 and 36 months after a mass distribution campaign in rural and urban settings in Senegal.
BMC Public Health
; 22(1): 719, 2022 04 11.
Article
in English
| MEDLINE | ID: mdl-35410149
2.
Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial.
Nat Med
; 30(1): 130-137, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38177851
3.
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.
BMJ Open
; 11(6): e047147, 2021 06 24.
Article
in English
| MEDLINE | ID: mdl-34168029
Results
1 -
3
de 3
1
Next >
>>